Erytech Pharma SA (NASDAQ:ERYP)

4.51
Delayed Data
As of Dec 10
 0.00 / 0.00%
Today’s Change
3.95
Today|||52-Week Range
10.65
-33.42%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Erytech Pharma SA have a median target of 23.36, with a high estimate of 29.73 and a low estimate of 13.00. The median estimate represents a +418.06% increase from the last price of 4.51.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Erytech Pharma SA. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.94
Sales
$1.7M
Reporting Date
Mar 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.97%
 
 
 
 
 
 
Growthannually -47.26%
 
 
 
 
 
 

Sales

Growthquarterly 70.31%
 
 
 
 
 
 
Growthannually 7.45%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.